The FDA’s Draft Guidance on Suspect Product, and Farewell Columbus

The FDA published the draft guidance on the identification of suspect product and notification of suspect and illegitimate product on June 11 as mandated by Congress in the Drug Supply Chain Security Act (DSCSA).  The document provides helpful suggestions for those who wish to reduce the risk that they will unknowingly acquire illegitimate product through

Looking for Serialization & Tracing Insights?

To get full access to this and other great RXTRACE_LOGO_Trans_250x94 essays, you need to
either Login, or upgrade your current subscription!
 Unlimited access is just a few clicks away!
To learn why RXTRACE_LOGO_Trans_250x94 is such a great value, click here.









One thought on “The FDA’s Draft Guidance on Suspect Product, and Farewell Columbus”

Comments are closed.